Apple has launched a large-scale research effort to understand how people actually use conversational AI for their health. The Apple Health AI Usage Study, announced Monday in the United States, is a virtual research study and companion app designed to examine what drives user trust, how well people comprehend AI-generated health answers, and whether those answers translate into everyday health actions.
The study, presented at the HLTH26 healthcare conference according to Fierce Healthcare, will enroll up to 200,000 eligible participants across the United States. It arrives at a moment when millions of people are already pasting symptoms into general-purpose chatbots, and when clinicians are increasingly turning to AI tools of their own — a shift tracked closely in the latest AI developments across the medical and consumer technology industries.
What the Study Will Measure
According to Apple's announcement, the study is designed to advance understanding of how people interact with conversational health AI tools by examining several dimensions: what drives user trust, the quality of the responses people receive, how well participants comprehend the information, and what everyday health actions follow from it.
The stated goal is to inform the responsible design of health AI experiences, both for Apple and for the wider industry. Rather than measuring only whether a model produces medically accurate output, the study will look at the full loop between question, answer and real-world behavior — the area where consumer health AI has drawn the most criticism.
A Partnership With OpenEvidence
The research is conducted in collaboration with OpenEvidence, a clinical AI platform that is widely used by healthcare professionals and generates answers grounded in established medical literature, including The New England Journal of Medicine, the Journal of the American Medical Association and Nature.
The pairing is deliberate. Study participants will be able to ask the study app everyday health questions and receive answers generated by medically grounded AI technology developed by OpenEvidence, delivered through an Apple-designed research experience. STAT, which covered the launch, described the result as an experimental health chat app built for the study.
"Patients and clinicians are both turning to AI, but the tools they use are being built and tested in separate worlds," said Robert M. Wachter, professor and chair of the Department of Medicine at UC San Francisco, in Apple's announcement. "When patients and doctors draw on versions of the same trustworthy tools, patients arrive prepared, conversations improve, and next steps happen seamlessly. Connecting these tools, and rigorously studying what works, is how we'll get there."
Who Can Join, and What Happens to the Data
The study is open to up to 200,000 eligible participants aged 21 and older across the United States. To enroll, participants must have an Apple Intelligence-enabled iPhone — iPhone 15 Pro or later — running iOS 26 or later, and can join through the study app.
Apple says the study was designed with privacy protections, transparency and clinical guardrails from the ground up. Study data will not be used to train AI models, according to the company. Participants retain control over whether to share HealthKit metrics or survey responses, and Apple says it has implemented security measures to protect the study data it maintains.
The study app also includes safety guardrails intended to detect certain concerning questions and surface appropriate resources — a nod to the edge cases that generic chatbots have repeatedly handled poorly when users describe medical crises or self-harm.
Why Apple Is Starting With Trust
"At Apple, we believe responsible innovation starts with scientific rigor and clinical grounding. Health is deeply personal, and conducting a dedicated research study is the most thoughtful way to understand how people engage with, comprehend, and evaluate health AI in everyday life," said Sumbul Desai, Apple's vice president of Health and Fitness, in the announcement.
The framing is characteristic of Apple's health strategy, which has consistently favored cautious, research-backed rollouts over rapid feature launches. By studying trust and comprehension directly — rather than shipping a medical chatbot and iterating in public — Apple is positioning rigor itself as the differentiator in a consumer health AI market that is growing faster than its evidence base.
What It Means for the Health AI Race
The launch signals two things for the broader industry. First, Apple is choosing to partner with an established clinical AI provider rather than build its own medical answer engine for this research, an acknowledgment that grounding medical AI in peer-reviewed literature is a specialized discipline. Second, the scale — up to 200,000 participants — would make this one of the largest studies of consumer interaction with health AI ever conducted, and its findings could shape how regulators, clinicians and platform companies judge what "responsible" health AI looks like.
Competitors are watching closely. As conversational AI moves into high-stakes domains like medicine, the companies that can demonstrate trust, comprehension and safety with published evidence — rather than benchmarks alone — are likely to have the strongest case with both users and health systems.
Stay Ahead of AI
Don't miss a beat as AI transforms healthcare, work and daily life. Read more AI news →
